Viking Therapeutics' founder and CEO Brian Lian
Viking Therapeutics
Brian Lian had been working as a Wall Street analyst for nearly a decade when he took a meeting that changed his life.
It was 20… [+8189 chars]
How A Wall Street Analyst Started A $4 Billion Obesity Drug Company - Forbes
Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and the GLP-1 space booming, it’s now a prime M&A target for giants jostling for their share of a potential $100 billion market.
By:Amy Feldman
Source:Forbes
Published:
Related News
S&P 500 futures higher as major averages advance for second straight day: Live updates - CNBC
Stocks rose for a second session Thursday on easing geopolitical fears, placing the Dow Industrials on track for a narrow weekly gain.
CNBC•Pia Singh
Asian Stocks to Gain After US Data, BOJ in Focus: Markets Wrap - Bloomberg.com
Asian stocks climbed to a record and the dollar held its losses as global investors favored non-US assets amid policy unpredictability and geopolitical risks. Precious metals also set new all-time highs.
Bloomberg•Anand Krishnamoorthy, Winnie Hsu
Bank of Japan raises economic growth forecasts ahead of snap election, holds rates at 0.75% - CNBC
The BOJ also upgraded its GDP forecast for the 2025 fiscal year to 0.9%, and also raised its GDP projection for the 2026 fiscal year to 1% from 0.7%.
CNBC•Lim Hui Jie